Skip to main content

Understanding unlicensed medicines

The purpose of this document is to provide guidance for improving the management of unlicensed ‘specials’ and off-label medicines in all sectors of healthcare in NHS Wales. This guidance encompasses primary care (general practice and community pharmacy), secondary care, and patients and carers.

⇩ Understanding unlicensed medicines 3.7MB (PDF)

(May 2023)

The patient information leaflets are available as separate downloads:

(Patient information leaflets published May 2023, Easy Read added Oct 2023) 

Equality and Health Impact Assessment (EqHIA) form

Follow AWTTC: